Navigation Links
Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results
Date:2/5/2010

Sunquest announced that its laboratory data systems help laboratories manage the H1N1 influenza epidemic by facilitating easy transfer of health results to the Centers for Disease Control or state public health departments.

(PRWEB) February 5, 2010 -- Sunquest, a leading provider of healthcare diagnostic information technology and outreach solutions, announced that its laboratory data systems help laboratories manage the H1N1 influenza epidemic by facilitating easy transfer of health results to the Centers for Disease Control or state public health departments. This enables Sunquest customers to meet a number of the new “Meaningful Use” guidelines spelled out in the American Recovery and Reinvestment Act of 2009.

The new guidelines authorize the Centers for Medicare & Medicaid Services (CMS) to provide reimbursement incentives for eligible professionals and hospitals who are successful in becoming “meaningful users” of certified electronic health record (EHR) technology. “Sunquest is connected to more Departments of Health for US States than any other laboratory IT provider in the global marketplace,” according to Kelly Feist, Sunquest’s vice president of marketing.

Specifically, two Sunquest solutions are actively aiding organizations as they strive to achieve meaningful use: Sunquest ICE Physician Portal and Sunquest Outreach Advantage. Physician Portal empowers hospitals to use effectively electronic medical records within their system and their community. As those hospitals connect with local physicians, Outreach Advantage enables seamless interoperability with EMR providers, enhancing relationships while driving businesses towards meaningful use.

“Sunquest’s mission has always been to provide laboratory customers with the tools to deliver meaningful use of their data, and we have been doing that for years," continues Feist. "Our award-winning Sunquest Laboratory™ builds workflow excellence into laboratory operations with such tools as intelligent rules, instrument result auto-verification, customizable patient and management reports, and data access for business intelligence. These tools have been of great assistance as laboratory systems obtain and share accurate data concerning the H1N1 epidemic.”

About Sunquest Information Systems
Sunquest Information Systems, Inc. delivers market leading diagnostic information technology and outreach solutions designed and implemented to fulfill the business objectives of today’s healthcare leaders. Headquartered in Tucson, Arizona, the company has offices in: Raleigh, North Carolina; Norwich, United Kingdom; and Bangalore, India. Sunquest serves the global marketplace with reliable technology required for mission critical applications. These solutions provide the foundation to optimize the healthcare experience, deliver safe, effective, and timely patient care, expand community reach, and transform the delivery of healthcare with predictive and personalized medicine.

For more information please visit www.sunquestinfo.com, or phone +1 (800) 748-0692.

# # #

Read the full story at http://www.prweb.com/releases/2010/02/prweb3569394.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Sunquest Advances Investment in Innovations Team
2. Sunquest Announces Significant Speaker Schedule for HIMSS 2010
3. Sunquest Introduces First Business Intelligence Solution in Laboratory Marketplace
4. Sunquest Information Systems Enters Into Business Relationship with Valley Medical Center of Washington
5. Sunquest Introduces the Integrated Clinical Environment Physician Portal to US Marketplace
6. FDA Consumer Health Information - FDAs MedWatch Safety Alerts: January 2010
7. Smoker alert: Information you can live with
8. BridgeGate and Information Builders form Strategic Partnership to Extend Integration Capability for Healthcare and Government Markets
9. FDA Consumer Health Information - Eat for a Healthy Heart
10. Brain Thermostat May Suppress Non-Essential Information
11. Health Systems, Hospitals and Universities Nationwide Chose Epocrates in 2009 for Trusted Point-of-Care Clinical Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: